Dr. Mohammad Khalil, MD

Dr. Khalil practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Khalil's NPI, 1669662136, was assigned on July 30, 2007. Dr. Khalil graduated from University of Jordan Faculty of Medicine in 2004. Dr. Khalil holds Texas license S3830.

Dr. Khalil's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Khalil's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Khalil is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Khalil to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalil practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khalil's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khalil is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Khalil's licenses on file in 4 states: Texas, Oklahoma, Kansas and Missouri.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Khalil treats.

CMS data shows 574 Medicare services from Dr. Khalil across 6 procedure codes in 2024, for 215 Medicare patients. Medicare paid $57,328 for them.

CMS counts 215 Medicare patients who saw Dr. Khalil in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalil's median patient age at 72, with 49% women.

In 2024, Dr. Khalil wrote 661 Medicare Part D claims for 97 patients. 75% of them were for generic drugs. CMS names the drug for 446 of them, across 19 drugs with 11 or more claims each, at $1,298,983 in total drug cost. In 2023, CMS named 344 claims across 16 drugs.

Dr. Khalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khalil as offering telehealth.

Dmand AI links 10 papers to Dr. Khalil, published from 2013 to 2018. 2014 was the busiest year, with 3. The most frequent topics are Leukemia, Myeloid, Acute. Dr. Khalil has published most often in J Vasc Access. Dr. Khalil's most frequent co-authors are Mohamad Ali Cherry, MD, Sami Ibrahimi, MD and Kellie R. Jones, MD.

CMS Open Payments shows 57 general payments to Dr. Khalil from 26 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Pfizer Inc. paid the most, $183.

Dr. Khalil graduated from University of Jordan Faculty of Medicine in 2004.

Dr. Khalil is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.